Epidermolysis Bullosa - 52 Studies Found

Not yet recruiting : Diacerin for the Treatment of Epidermolysis Bullosa Simplex
: Epidermolysis Bullosa Simplex
: 2015-05-27
: Drug: Diacerin cream Diacerin tablet solubule in ultraphil cream
Completed : Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa
: Epidermolysis Bullosa With Mitten Hands
: 2013-07-23
: Biological: Cell transplantation autologous transplantation of cultured fibroblast on amniotic membrane
Completed : Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
: Epidermolysis Bullosa Acquisita
: 1999-10-18
: Drug: methoxsalen
Not yet recruiting : Safety and Efficacy of Diacerein 1% Ointment Topical Formulation Compared to Placebo for Subjects With Epidermolysis Bullosa Simplex (EBS)
: Epidermolysis Bullosa Simplex
: 2017-05-10
:
  • Drug: Diacerein 1% Ointment Topical Formulation

Completed : Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
: Epidermolysis Bullosa Simplex
: 2009-07-08
:
  • Drug: Dysport® (Botulinumtoxin A (Btx A))

Recruiting : Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
:
  • Epidermolysis Bullosa Simplex
  • Pachyonychia Congenita

: 2015-10-29
:
  • Drug: Jojoba oil with broccoli sprout extract

RECRUITING : A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare� Matrix) for Wound Healing in RDEB Patients
: Recessive Dystrophic Epidermolysis Bullosa
: 2024-11-21
: The Spincare device, developed by Nanomedic, is the first portable tool that delivers a non-invasive, non-therapeutic electrospun, nanofibrous matrix
RECRUITING : Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
: Epidermolysis Bullosa
: 2024-11-21
: Allogeneic dermal ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs)
NOT_YET_RECRUITING : Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
: Dystrophic Epidermolysis Bullosa
: 2024-11-21
: poloxamer hydrogel for topical administration
RECRUITING : EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
: Epidermolysis Bullosa
: 2024-11-21
: EB-101 autologous RDEB keratinocytes isolated from skin biopsies and transduced with a recombinant retrovirus containing a full-length COL7A1 expre
<<< Previous | Next >>>